Safely Prescribing GLP-1 Medications for Older Adults: Remote care solutions that offer protection and connection
![body-comp-pro-lifestyle](https://withingshealthsolutions.com/wp-content/uploads/2023/08/BCP-email-header-1024x672.png)
Remote care solutions, like connected devices and remote patient monitoring allow for safer GLP-1 use in older adults.
Part 3: Supporting Safe and Sustainable Weight Loss With GLP-1s – Managing weight after medication
![](https://withingshealthsolutions.com/wp-content/uploads/2023/08/ezgif-4-c1e7f90113-scaled-1-1024x683.jpg)
Weight gain is likely when patients stop taking a GLP-1 therapy. A 2022 study found patients who took the GLP-1 semaglutide had regained two thirds of their prior weight and had similar cardiometabolic changes a year after stopping the medication. Prescribers at doctor’s offices and virtual weight loss programs should track patients throughout their journey and when they stop taking GLP-1s. This monitoring of daily progress provides long-term oversight of weight loss goals and maintenance.
Part 2: Supporting Safe and Sustainable Weight Loss With GLP-1s – Why body composition matters
![body-pro-scale-lifestyle](https://withingshealthsolutions.com/wp-content/uploads/2023/09/DSC_5693-scaled.webp)
GLP-1 agonists are remarkably effective in helping patients lose weight. But this can’t be done in a vacuum. One data point that’s often overlooked in a patient’s journey on GLP-1s is body composition.
Part 1: Supporting Safe and Sustainable Weight Loss With GLP-1s – Finding the right remote health technologies
![](https://withingshealthsolutions.com/wp-content/uploads/2023/08/ezgif-4-65f1984099-1-1024x683.jpg)
New medications like GLP-1 agonists offer a promising tool to help patients achieve a healthy weight. But supporting patients in long-term weight loss involves more than medication.